
Development and distribution of the CE-marked medical device Gondola AMPS for mechanical foot stimulation in Parkinson's disease.

Gondola Medical Technologies SA
Epalinges (Switzerland)New on Amplifa
About Gondola Medical Technologies
Gondola Medical Technologies SA is a Swiss medical technology company based in Epalinges near Lausanne. The company develops and distributes the internationally patented and CE-marked medical device Gondola AMPS, which is based on the mechanical stimulation of specific points on both feet. The non-invasive application takes about two minutes and is intended to reactivate brain areas that control gait and balance; it is designed for regular use and can be combined with existing Parkinson's treatments. The efficacy and safety of the therapy have been documented in clinical studies with more than 300 Parkinson's patients; among the parameters investigated were walking speed, stride length and gait symmetry. AMPS therapy is offered in specialist centers and partner centers, with use taking place under the supervision of trained teams. The company was founded in 2011 by Francesco Cecchini on the basis of a clinical observation by co-founder and CTO Dr. Stefano Tassin. The company is registered in the Swiss commercial register and is subject to the supervision of the Notified Body Kiwa Cermet Italia Spa.
- Site
- Epalinges
- Processes
- Gondola AMPS therapy (mechanical foot stimulation for people with Parkinson's), Treatment in partner centers
- Certificates
- CE marking (EU MDR)
- Founded
- 2011
- Industries
- Medical technology, Neurology/Parkinson's therapy
- 01
Research and development of AMPS therapy
- 02
Manufacturing and finishing of the medical device
- 03
Quality inspection and CE conformity under EU MDR
- 04
Distribution and application in partner centers and specialist centers
- 05
Accompanying clinical research
Locations

Epalinges
CHHeadquarters
Products


Inside the production





Industries
Additional services
Quality and Approval
The medical device Gondola AMPS carries the CE mark in accordance with the EU Medical Device Regulation (MDR); conformity is monitored by the Notified Body Kiwa Cermet Italia Spa. The safety and efficacy of the therapy are documented in clinical studies with more than 300 Parkinson's patients.
| Evidence | Epalinges |
|---|---|
| CE marking (EU MDR) |
History
- Frühe 2000er
Dr. Stefano Tassin observes during a rehabilitation session that stimulation of a specific foot point causes an immediate improvement in walking ability in a Parkinson's patient
- 2011
Foundation of Gondola Medical Technologies by Francesco Cecchini in Switzerland
- Heute
The Gondola technology is used in numerous specialist centers, is validated through clinical studies and scientific publications, and has been investigated in clinical studies in more than 300 patients